VGI Health Technology Limited (NSX:VTL) Quarterly Update
The Directors of VGI Health Technology Limited (NSX:VTL) are pleased to provide the following update for the quarter ending 31 December 2022.
The Directors of VGI Health Technology Limited (NSX:VTL) are pleased to provide the following update for the quarter ending 31 December 2022.
American Medical Association approves CPT PLA code for PromarkerD predictive test for diabetic kidney disease
Fiji Kava Ltd (ASX:FIJ), a health and wellness company with operations in Australia, Fiji, and the USA, provides shareholders the following update on the acquisition of Leilo Inc. USA.
On 5 April 2022, the Directors of VGI Health Technology Limited (NSX:VTL) announced the sale of its wholly owned subsidiary, Invictus BioPharma Pty Ltd to Invictus BioPharma Holdings Ltd (IVBHL) (the Transaction).
Fiji Kava Limited (ASX:FIJ), a health and wellness company with operations in Australia, Fiji, and the USA. The company which produces natural products to reduce anxiety, promote relaxation, improve sleep, and support sports recovery and performance, has appointed ANZ Pharma as exclusive distributor in New Zealand.
Fiji Kava Limited (ASX:FIJ) advises that Mr Nicholas Simms has retired by rotation as a Director of Fiji Kava Ltd and all subsidiaries.
Fiji Kava Limited (ASX:FIJ) an Australian-Fijian medicinal Kava company which produces products for the natural medicine market has confirmed the nationwide listing of their dietary shots range across Vitamin Shoppe nationally in the USA, in April 2023.